A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

ABSTRACT:

Background

Most proton pump inhibitors inhibit the bioactivation of clopidogrel to its active metabolite. The clinical significance of this drug interaction is unknown.

Methods

We conducted a population-based nested case-control study among patients aged 66 years or older who commenced clopidogrel between Apr. 1, 2002, and Dec. 31, 2007, following hospital discharge after treatment of acute myocardial infarction. The cases in our study were those readmitted with acute myocardial infarction within 90 days after discharge. We performed a secondary analysis considering events within 1 year. Event-free controls (at a ratio of 3:1) were matched to cases on age, percutaneous coronary intervention and a validated risk score. We categorized exposure to proton pump inhibitors before

SUBMITTER: Juurlink DN 

PROVIDER: S-EPMC2659819 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature